Episode 282: Holiday Special - Bladder Cancer in 2023

Dr. Kala Sridhar joins the podcast to discuss updates and advancements in the bladder cancer field in 2023, including EV-302 and the ideal patients to receive enfortumab vedotin and pembrolizumab.
Dr. Sridhar is a Professor in the Department of Medicine at the University of Toronto and a Genitourinary Medical Oncologist at the Princess Margaret Cancer Center, as well as Chair of the Genitourinary Medical Oncologists of Canada and Vice Chair of the Medical Advisory Board of Bladder Cancer Canada.